CD274 and mesothelioma: Additionally, we have identified a 72-hour postradiation time point at which increased inhibition of cell proliferation was consistently observed across several cell lines; this may be an ideal time for combination with immunotherapies (eg, anti-PD-L1), because response rates in mesothelioma are still generally low.